India, July 30 -- India's Active Pharmaceutical Ingredient makers are increasingly consolidating group structures to simplify ownership, strengthen balance sheets and present cleaner financials to investors as the sector scales up capacity to meet rising global demand for bulk drugs meeting stringent international quality standards.

Anlon Healthcare shares fell 7.62% to Rs. 14.67 on Thursday, against a previous close of Rs. 15.88, after opening at Rs. 15.85 and touching an intraday low of Rs. 14.18. The stock's market capitalization stood near Rs. 779.73 crore.

What's the News? Anlon Healthcare Limited's board, at a meeting held on July 30, 2026, approved unaudited standalone and consolidated financial results for the quarter ended Jun...